Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Voulgaris (Alexandroupolis, Greece), K. Archontogeorgis (Alexandroupolis, Greece), E. Nena (Alexandroupolis, Greece), M. Xanthoudaki (Alexandroupolis, Greece), P. Ntolios (Alexandroupolis, Greece), M. Kouratzi (Alexandroupolis, Greece), S. Anevlavis (Alexandroupolis, Greece), M. Froudarakis (Alexandroupolis, Greece), P. Steiropoulos (Alexandroupolis, Greece). Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome). 2503

Member's Comments

No comment yet.

Related content which might interest you: Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovasculer diseases Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Mean platelet volume in patients with obstructive sleep apnea syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome) Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease? Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)” Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome) Source: Sleep and Breathing Conference 2021 Year: 2021 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate  sleep apnea  (overlap syndrome). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016